Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic ??T Cell Therapies Addressing Solid Tumors
? Acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging ??T cells for the potential...






